Skip to main content
. 2021 May 9;24(1):502. doi: 10.3892/mmr.2021.12141

Figure 9.

Figure 9.

Graphical summary of the potential signaling pathways involved in the role of constitutive expression of ADAM33 in VSMCs for maintaining a proliferative phenotype of airway VSMCs. ADAM33, a disintegrin and metalloproteinase-33; VSMCs, vascular smooth muscle cells; p-, phosphorylated.